Pricing

Log inSign up

Attralus Therapeutics

0 followers

‌

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Mark Timney
CEO

Mark Timney

Collapse
Spencer Guthrie
Co-Founder & COO
Glen Firestone
Chief Business Officer
Gregory Bell
Chief Medical Officer
Jonathan Wall
Co-Founder & Interim Chief Scientific Officer
James Testa
VP, Finance
Michael L. Klein
Head, CMC
Christine Huh
Head, Human Resources
Andy Vick
Vice President, Head Of Toxicology, Drug Disposition, And Pk/pd
Daniel Kim
Associate Director, Translational Medicine Operations
Lesley Davis
Director Of Quality
Mike Klein
Senior Vice President, Head of CMC
Nicolas Angell
Executive Director, Analytical and Formulation Development
DC
Dave Conroy
Head of Program Management
Matthew Meldorf
Senior Vice President Clinical Development

Teams

+10

Regulatory and Scientific Development

13 members

+4

Clinical Operations and Development

7 members

+3

Leadership Team

6 members

Similar companies

Regeneron

92 followers

BeiGene

19 followers

Cytiva

10 followers

Verve Therapeutics

54 followers

Tempus Labs

16 followers

MedGenome

6 followers

ReCode Therapeutics

1 follower

Protagonist Therapeutics

1 follower

SCIEX

1 follower

University of California, Irvine

15 followers

Priovant

2 followers

Explore companies